These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24862318)

  • 1. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
    Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
    J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
    Duong HH; Yung LY
    Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
    Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
    J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine.
    Markovsky E; Eldar-Boock A; Ben-Shushan D; Baabur-Cohen H; Yeini E; Pisarevsky E; Many A; Aviel-Ronen S; Barshack I; Satchi-Fainaro R
    J Control Release; 2017 Mar; 249():162-172. PubMed ID: 28159518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release.
    Ferber S; Baabur-Cohen H; Blau R; Epshtein Y; Kisin-Finfer E; Redy O; Shabat D; Satchi-Fainaro R
    Cancer Lett; 2014 Sep; 352(1):81-9. PubMed ID: 24614283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
    Eldar-Boock A; Miller K; Sanchis J; Lupu R; Vicent MJ; Satchi-Fainaro R
    Biomaterials; 2011 May; 32(15):3862-74. PubMed ID: 21376390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
    Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
    Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable poly(organophosphazene) hydrogel system for effective paclitaxel and doxorubicin combination therapy.
    Cho JK; Kuh HJ; Song SC
    J Drug Target; 2014 Sep; 22(8):761-7. PubMed ID: 24937548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug.
    Ahmed F; Pakunlu RI; Brannan A; Bates F; Minko T; Discher DE
    J Control Release; 2006 Nov; 116(2):150-8. PubMed ID: 16942814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles.
    Wang Y; Ma S; Xie Z; Zhang H
    Colloids Surf B Biointerfaces; 2014 Apr; 116():41-8. PubMed ID: 24441457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of zwitterionic polymer-based doxorubicin conjugates: tuning the surface charge to prolong the circulation and reduce toxicity.
    Wang Z; Ma G; Zhang J; Lin W; Ji F; Bernards MT; Chen S
    Langmuir; 2014 Apr; 30(13):3764-74. PubMed ID: 24617705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
    Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
    J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A facile strategy to generate polymeric nanoparticles for synergistic chemo-photodynamic therapy.
    Deng X; Liang Y; Peng X; Su T; Luo S; Cao J; Gu Z; He B
    Chem Commun (Camb); 2015 Mar; 51(20):4271-4. PubMed ID: 25673062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.